v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (22,043) $ (101,826)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 352 283
Stock-based compensation 6,238 9,161
Amortization/accretion of debt-related costs 803 1,042
Accretion of marketable securities purchased at a discount (2,540) (4,713)
Other non-cash adjustments (1,561) (397)
Changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 1,290 (1,610)
Decrease (increase) in inventories 63 (204)
Decrease (increase) in prepaid expenses and other current assets 806 (2,545)
Decrease in other long-term assets 376 337
Decrease in accounts payable and other liabilities (10,569) (3,198)
Net cash used in operating activities (26,785) (103,670)
Cash flows from investing activities:    
Purchases of property and equipment 0 250
Purchases of investments (90,943) (260,297)
Maturities of investments 147,008 138,000
Net cash provided by (used in) investing activities 56,065 (122,547)
Cash flows from financing activities:    
Proceeds from issuance of common stock for equity incentive plans 0 89
Proceeds from issuance of preferred stock, net of fees 0 241,410
Payments for tax withholding on share-based compensation vesting 572 1,730
Repayment of debt borrowings (45,000) 0
Other debt financing fees 0 (400)
Net cash (used in) provided by financing activities (45,572) 239,369
Net (decrease) increase in cash, cash equivalents and restricted cash (16,292) 13,152
Cash, cash equivalents, and restricted cash at beginning of period 66,656 22,465
Cash, cash equivalents, and restricted cash at end of period 50,364 35,617
Supplemental disclosure of cash flow information:    
Cash paid for interest 4,888 6,512
Supplemental disclosure of non-cash investing and financing activities:    
Accrued financing costs 0 910
Conversion of preferred stock to common stock $ 0 $ 115